- Home
- ARCT vs OM Comparison
ARCT vs OM Comparison
Compare ARCT & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- OM
- Stock Information
- Founded
- ARCT 2013
- OM 2003
- Country
- ARCT United States
- OM United States
- Employees
- ARCT N/A
- OM N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ARCT Health Care
- OM Health Care
- Exchange
- ARCT Nasdaq
- OM Nasdaq
- Market Cap
- ARCT 298.3M
- OM 305.5M
- IPO Year
- ARCT N/A
- OM 2020
- Fundamental
- Price
- ARCT $11.89
- OM $20.12
- Analyst Decision
- ARCT Strong Buy
- OM Buy
- Analyst Count
- ARCT 8
- OM 2
- Target Price
- ARCT $52.33
- OM $33.00
- AVG Volume (30 Days)
- ARCT 484.3K
- OM 284.9K
- Earning Date
- ARCT 08-04-2025
- OM 05-07-2025
- Dividend Yield
- ARCT N/A
- OM N/A
- EPS Growth
- ARCT N/A
- OM N/A
- EPS
- ARCT N/A
- OM N/A
- Revenue
- ARCT $143,680,000.00
- OM $115,273,000.00
- Revenue This Year
- ARCT N/A
- OM $10.80
- Revenue Next Year
- ARCT $39.32
- OM $11.99
- P/E Ratio
- ARCT N/A
- OM N/A
- Revenue Growth
- ARCT 15.38
- OM N/A
- 52 Week Low
- ARCT $8.04
- OM $5.85
- 52 Week High
- ARCT $45.00
- OM $72.60
- Technical
- Relative Strength Index (RSI)
- ARCT 48.75
- OM 61.31
- Support Level
- ARCT $11.51
- OM $16.73
- Resistance Level
- ARCT $13.27
- OM $19.80
- Average True Range (ATR)
- ARCT 0.82
- OM 1.45
- MACD
- ARCT 0.01
- OM -0.19
- Stochastic Oscillator
- ARCT 26.15
- OM 50.61
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.